Gene Regulation and Epigenetics

1. Prokaryotic Operons

Prokaryotes organize functionally related genes into operons — a single promoter transcribes a polycistronic mRNA encoding multiple proteins. This arrangement allows coordinated regulation. The lac operon (inducible, catabolic) encodes β-galactosidase, permease, and transacetylase for lactose metabolism. In the absence of lactose, the LacI repressor binds the operator and blocks transcription. When lactose is present, its isomer allolactose acts as an inducer, binding LacI and causing it to dissociate from the operator. Additionally, CAP (catabolite activator protein) binds cAMP and activates transcription only when glucose is low — a classic example of dual (negative and positive) control integrating two environmental signals. Conversely, the trp operon (repressible, anabolic) encodes enzymes for tryptophan biosynthesis. When tryptophan levels are high, tryptophan binds the TrpR repressor as a corepressor, enabling it to bind the operator and shut down transcription. The trp operon also features attenuation — a leader peptide with tandem tryptophan codons that causes premature transcription termination when tryptophan is abundant, adding a second regulatory layer.

2. Eukaryotic Transcriptional Regulation

Eukaryotic transcription requires far more regulatory complexity. The core promoter contains the TATA box (~−30), recognized by TATA-binding protein (TBP, a subunit of TFIID), CAAT box, and GC box. General transcription factors (TFIIA, B, D, E, F, H) assemble with RNA polymerase II into the pre-initiation complex at the promoter. But this basal machinery alone produces minimal transcription. Regulatory transcription factors (activators and repressors) bind enhancers — cis-acting DNA elements that can be located thousands of base pairs upstream, downstream, or even within introns, and function independently of orientation. Enhancer-bound activators recruit coactivators (e.g., Mediator, histone acetyltransferases) that loop to the promoter and stimulate initiation. Silencers recruit repressors that antagonize activation. Combinatorial control — the integration of multiple transcription factor inputs at a gene's regulatory region — enables exquisite specificity: a given gene may require the simultaneous presence of several activators and the absence of repressors. Insulators (boundary elements) block enhancer-promoter communication, partitioning the genome into independent regulatory domains.

3. Chromatin Remodeling

In eukaryotes, DNA is wrapped around histone octamers to form nucleosomes, which are further compacted into chromatin fibers. Euchromatin is decondensed and transcriptionally active; heterochromatin is densely packed and silenced (constitutive heterochromatin: centromeres, telomeres; facultative heterochromatin: developmentally silenced regions like the inactive X). For transcription factors to access their binding sites, chromatin structure must be locally altered. ATP-dependent chromatin remodeling complexes use the energy of ATP hydrolysis to slide, eject, or restructure nucleosomes. The SWI/SNF complex (yeast) / BAF complex (mammals) disrupts histone-DNA contacts to expose regulatory sequences. The ISWI family spaces nucleosomes evenly, while NuRD couples remodeling with histone deacetylation for repression. Chromatin remodeling is not a one-way street — it is dynamically regulated, and defects in remodeling complexes (e.g., mutations in SWI/SNF subunits) are found in ~20% of human cancers.

4. Histone Modification

The N-terminal tails of histones protrude from the nucleosome core and are subject to extensive covalent modification — acetylation, methylation, phosphorylation, ubiquitination, and sumoylation — creating what is termed the histone code. Histone acetyltransferases (HATs) transfer acetyl groups to lysine residues (e.g., H3K9ac, H3K27ac), neutralizing the positive charge and weakening histone-DNA interaction, resulting in open, transcriptionally permissive chromatin. Histone deacetylases (HDACs) remove acetyl marks, restoring tight packing and repression. Histone methyltransferases (HMTs) add methyl groups at lysine or arginine residues; the effect depends on the specific residue and the number of methyl groups — H3K4me3 (trimethylation of lysine 4) marks active promoters, while H3K9me3 and H3K27me3 mark silenced chromatin. The Polycomb repressive complex (PRC2) deposits H3K27me3, and PRC1 compacts chromatin. Effector proteins with specific domains (bromodomains recognize acetylation; chromodomains recognize methylation) read the code and execute downstream functional consequences.

5. DNA Methylation

DNA methyltransferases (DNMTs) catalyze the addition of a methyl group to the 5-carbon position of cytosine, predominantly at CpG dinucleotides. DNMT1 is the maintenance methyltransferase — it recognizes hemimethylated DNA after replication and methylates the newly synthesized strand, ensuring faithful propagation of methylation patterns through mitosis. DNMT3a and DNMT3b are de novo methyltransferases that establish new methylation marks during development. CpG islands — GC-rich regions near ~60% of human gene promoters — are typically unmethylated in active genes. Hypermethylation of CpG islands at tumor suppressor gene promoters is a hallmark of many cancers, causing heritable transcriptional silencing. Methyl-CpG-binding domain (MBD) proteins (e.g., MeCP2) recognize methylated DNA and recruit HDACs and repressive chromatin remodelers. DNA demethylation occurs passively (failure to maintain during replication) or actively through TET (ten-eleven translocation) enzymes, which oxidize 5-methylcytosine to 5-hydroxymethylcytosine and further intermediates that are excised by base-excision repair.

6. Epigenetic Inheritance

Epigenetic marks can be transmitted through cell division — mitotic inheritance — allowing daughter cells to remember their identity (e.g., a hepatocyte produces hepatocytes). More controversially, some epigenetic marks survive meiosis and are passed to offspring — transgenerational epigenetic inheritance. Two classic examples of epigenetic phenomena: Genomic imprinting is parent-of-origin-specific silencing, where only one allele (maternal or paternal) is expressed. The IGF2 gene is expressed only from the paternal allele; the maternal allele is silenced by methylation at an imprinting control region. Errors in imprinting cause disorders such as Prader-Willi and Angelman syndromes (both involve 15q11-q13). X-inactivation in female mammals equalizes X-linked gene dosage between XX females and XY males. Early in development, one X chromosome is randomly chosen and coated by the long noncoding RNA XIST, which recruits Polycomb repressive complexes, depositing H3K27me3 and DNA methylation to form a stably silenced Barr body. Epigenetic reprogramming — global erasure and re-establishment of marks — occurs during primordial germ cell development and again in the zygote, ensuring totipotency.

7. Gene Expression Experiments

MCAT passages frequently describe techniques for measuring gene expression and protein-DNA interactions. Northern blot: mRNA separated by electrophoresis, transferred to membrane, probed with labeled complementary DNA — reveals transcript size and abundance. RT-qPCR (reverse transcription quantitative PCR): reverse transcribes mRNA to cDNA, then amplifies with fluorescent detection to quantify transcript levels with high sensitivity. Reporter gene assays: fuse the regulatory region of interest to a reporter (luciferase, GFP, β-galactosidase); the measured enzymatic activity or fluorescence reflects promoter/enhancer activity. ChIP (chromatin immunoprecipitation): crosslink proteins to DNA, fragment chromatin, immunoprecipitate with an antibody against the protein of interest (e.g., a transcription factor or modified histone), then identify bound DNA by PCR (ChIP-qPCR) or sequencing (ChIP-seq). EMSA (electrophoretic mobility shift assay; gel shift): a labeled DNA probe is incubated with protein extract; protein-DNA complexes migrate more slowly through a native gel. Bisulfite sequencing: bisulfite treatment converts unmethylated cytosines to uracil while methylated cytosines are protected; subsequent sequencing reveals methylation patterns at single-nucleotide resolution. RNA-seq provides transcriptome-wide quantification.

How it works

The lac operon as a logic gate. Imagine the lac operon as an AND gate integrating two environmental signals: (1) IS LACTOSE PRESENT? If yes, allolactose inactivates the LacI repressor → operator unblocked. (2) IS GLUCOSE ABSENT? If yes, cAMP levels rise, CAP binds cAMP, and CAP-cAMP binds the CAP site upstream of the promoter, recruiting RNA polymerase. Only when BOTH conditions are met — lactose present AND glucose absent — is the operon fully transcribed. If glucose is present, cAMP is low, CAP does not bind, and transcription is minimal even with the repressor removed — the cell prioritizes glucose, the preferred energy source.

The trp operon and attenuation. Beyond simple repressor logic, the trp operon uses attenuation for fine-tuning. The 5′ leader region of the trp mRNA contains two consecutive tryptophan codons and can fold into alternative stem-loop structures. When tryptophan is abundant, ribosomes translate the leader rapidly, and a terminator stem-loop forms, causing RNA polymerase to abort transcription before reaching the structural genes. When tryptophan is scarce, ribosomes stall at the Trp codons, an antiterminator structure forms, and transcription proceeds. This elegant mechanism allows the cell to sense tryptophan availability through translation rate — coupling transcription and translation, something eukaryotes cannot do because their processes are spatially separated (nucleus vs. cytoplasm).

Enhancer/silencer logic. Eukaryotic enhancers work through DNA looping. An activator bound to an enhancer thousands of base pairs away from the promoter contacts the basal transcription machinery via the Mediator complex, with the intervening DNA looped out. Multiple activators can cooperate, and different combinations across enhancers and silencers produce distinct expression patterns in different tissues. A single transcription factor (e.g., MyoD) can orchestrate an entire differentiation program by binding enhancers of hundreds of target genes. Insulators (bound by CTCF protein) partition the genome into topologically associating domains (TADs), ensuring that an enhancer activates only its intended promoter.

Chromatin states as a regulatory landscape. Chromatin exists in a continuum from fully closed (heterochromatin) to fully open (euchromatin), with histone modifications acting as signposts: H3K4me3 marks active promoters, H3K27ac marks active enhancers, H3K36me3 marks transcribed gene bodies, H3K9me3 marks constitutive heterochromatin, and H3K27me3 marks Polycomb-repressed regions. "Bivalent domains" — promoters marked simultaneously with H3K4me3 (active) and H3K27me3 (repressive) — poise developmental genes for rapid activation or permanent silencing during differentiation. This system explains how embryonic stem cells maintain pluripotency: key lineage-specifying genes are kept in a poised state, neither fully on nor fully off.

How it works

The lac operon as a logic gate. Imagine the lac operon as an AND gate integrating two environmental signals: (1) IS LACTOSE PRESENT? If yes, allolactose inactivates the LacI repressor → operator unblocked. (2) IS GLUCOSE ABSENT? If yes, cAMP levels rise, CAP binds cAMP, and CAP-cAMP binds the CAP site upstream of the promoter, recruiting RNA polymerase. Only when BOTH conditions are met — lactose present AND glucose absent — is the operon fully transcribed. If glucose is present, cAMP is low, CAP does not bind, and transcription is minimal even with the repressor removed — the cell prioritizes glucose, the preferred energy source.

The trp operon and attenuation. Beyond simple repressor logic, the trp operon uses attenuation for fine-tuning. The 5′ leader region of the trp mRNA contains two consecutive tryptophan codons and can fold into alternative stem-loop structures. When tryptophan is abundant, ribosomes translate the leader rapidly, and a terminator stem-loop forms, causing RNA polymerase to abort transcription before reaching the structural genes. When tryptophan is scarce, ribosomes stall at the Trp codons, an antiterminator structure forms, and transcription proceeds. This elegant mechanism allows the cell to sense tryptophan availability through translation rate — coupling transcription and translation, something eukaryotes cannot do because their processes are spatially separated (nucleus vs. cytoplasm).

Enhancer/silencer logic. Eukaryotic enhancers work through DNA looping. An activator bound to an enhancer thousands of base pairs away from the promoter contacts the basal transcription machinery via the Mediator complex, with the intervening DNA looped out. Multiple activators can cooperate, and different combinations across enhancers and silencers produce distinct expression patterns in different tissues. A single transcription factor (e.g., MyoD) can orchestrate an entire differentiation program by binding enhancers of hundreds of target genes. Insulators (bound by CTCF protein) partition the genome into topologically associating domains (TADs), ensuring that an enhancer activates only its intended promoter.

Chromatin states as a regulatory landscape. Chromatin exists in a continuum from fully closed (heterochromatin) to fully open (euchromatin), with histone modifications acting as signposts: H3K4me3 marks active promoters, H3K27ac marks active enhancers, H3K36me3 marks transcribed gene bodies, H3K9me3 marks constitutive heterochromatin, and H3K27me3 marks Polycomb-repressed regions. "Bivalent domains" — promoters marked simultaneously with H3K4me3 (active) and H3K27me3 (repressive) — poise developmental genes for rapid activation or permanent silencing during differentiation. This system explains how embryonic stem cells maintain pluripotency: key lineage-specifying genes are kept in a poised state, neither fully on nor fully off.

Comparisons

• Biochemistry: Enzyme regulation is paralleled at the genetic level — induction (lac operon), repression (trp operon), and feedback inhibition are distinct but complementary regulatory strategies. Understand the difference: feedback inhibition acts on existing enzyme molecules; operon regulation controls enzyme synthesis.
• Genetics: Mutations in regulatory elements (operator, promoter, CAP site) produce distinct phenotypes — operator-constitutive (Oᶜ) mutations prevent repressor binding and cause constitutive expression, while repressor mutations (I⁻) fail to repress. Contrast cis-acting (operator, promoter) vs. trans-acting (repressor protein, CAP) mutations. Epigenetics blurs the Mendelian boundary — imprinting produces non-Mendelian inheritance patterns where the phenotype depends on which parent contributed the allele.
• Cell Biology: X-inactivation, genomic imprinting, and cellular differentiation all depend on chromatin structure. The Barr body is a cytologically visible heterochromatin mass, a classic MCAT example linking epigenetics to cell biology. The concept that differentiated cells can be reprogrammed (induced pluripotent stem cells, iPS cells, via Yamanaka factors) shows that epigenetic marks are reversible.
• Pharmacology: HDAC inhibitors (vorinostat, romidepsin) and DNMT inhibitors (azacitidine, decitabine) are FDA-approved cancer therapies that reactivate epigenetically silenced tumor suppressor genes. Understanding their mechanism — reversing abnormal histone deacetylation or DNA hypermethylation — ties molecular biology directly to clinical medicine.
• Development & Disease: Rett syndrome (MeCP2 mutations), Rubinstein-Taybi syndrome (CBP/p300 HAT mutations), and Fragile X syndrome (CGG repeat expansion → DNA methylation of FMR1 promoter) are all disorders of epigenetic machinery. The MCAT may embed these in passages to test understanding of chromatin biology.

Common confusions

• Inducible ≠ repressible — follow the metabolic logic. The lac operon is inducible because the default state is OFF (repressor bound), and the inducer (allolactose) turns it ON. The trp operon is repressible because the default state is ON, and the corepressor (tryptophan) turns it OFF. Catabolic operons tend to be inducible (you only make the enzymes when the substrate is present); anabolic operons tend to be repressible (you stop making the enzymes when the end product is abundant). The MCAT will test whether you can predict operon type from the pathway function.
• DNA methylation at CpG islands silences — but methylation at gene bodies does not. CpG island promoter methylation is repressive. However, DNA methylation within gene bodies (exons/introns) is associated with active transcription and may suppress spurious intragenic initiation. Do not assume all DNA methylation silences expression — context matters. Similarly, H3K9 methylation is repressive; H3K4 methylation is activating.
• Enhancers and silencers are cis-acting; transcription factors are trans-acting. An enhancer mutation that prevents activator binding is cis-acting — it affects only the gene on the same chromosome and cannot be rescued by providing a normal enhancer on a different chromosome. Conversely, a transcription factor mutation is trans-acting — it can be rescued by a wild-type allele in a diploid organism. MCAT questions often require you to infer whether a mutation is cis or trans based on complementation test logic.
• Histone acetylation activates, not represses. This trips students up because the mechanism seems counterintuitive — adding a chemical group opens chromatin. Remember: acetylation neutralizes the positive charge on lysine, weakening the electrostatic interaction with negatively charged DNA, loosening nucleosome packing. HATs = on; HDACs = off. Deacetylation = compaction = silencing.
• Epigenetic inheritance is about chromatin marks, not DNA sequence changes. The MCAT definition of epigenetics requires heritability through cell division. A transcription factor temporarily activating a gene is regulation, not epigenetics — unless the activated state is maintained after the initial signal is gone and propagated through mitosis. DNA methylation is the best-understood mechanism of truly heritable epigenetic silencing.
• Experiment technique matching. When a passage describes identifying where a transcription factor binds genome-wide, the technique is ChIP-seq (not RNA-seq, not Northern blot). RNA-seq measures transcript abundance; ChIP-seq identifies protein-DNA binding sites; bisulfite sequencing maps methylation; EMSA detects protein-DNA binding in vitro. The MCAT frequently tests the ability to choose the correct technique for a given experimental question.

Quick review

• lac operon (inducible): default OFF. Allolactose = inducer, LacI = repressor. CAP-cAMP = positive control (glucose absent → cAMP high → CAP binds → activate). Dual signal AND gate.
• trp operon (repressible): default ON. Tryptophan = corepressor binds TrpR → operator blocked. Attenuation adds fine-tuning via leader peptide ribosome stalling.
• Operon logic: Catabolic = inducible (substrate triggers). Anabolic = repressible (product inhibits). cis-acting: operator/promoter. trans-acting: repressor/CAP proteins.
• Eukaryotic regulators: Enhancers (orientation/distance independent, cis-acting), silencers, insulators (CTCF). Promoter: TATA box, TBP, 5 general TFs + RNA Pol II = PIC. Combinatorial control.
• Chromatin remodeling: Euchromatin (open) vs. heterochromatin (closed). SWI/SNF, ISWI, NuRD complexes use ATP to slide/restructure nucleosomes. ~20% cancers have SWI/SNF mutations.
• Histone code: HATs = acetylation = open (bromodomains read). HDACs = deacetylation = closed. H3K4me3 = active promoters; H3K9me3, H3K27me3 = silencing. Polycomb PRC2/PRC1.
• DNA methylation: DNMT1 (maintenance), DNMT3a/3b (de novo). CpG islands — methylated = silenced. MBD proteins → recruit HDACs. TET enzymes = active demethylation. Epigenetic reprogramming in germline/zygote.
• Epigenetic inheritance: Genomic imprinting — parent-of-origin silencing (IGF2 paternal only). X-inactivation: XIST lncRNA → Polycomb → H3K27me3 + DNA methylation → Barr body. iPS cells (Yamanaka factors) show epigenetic reversibility.
• Techniques: Northern blot (mRNA size/abundance). RT-qPCR (mRNA quantification). Reporter assay (promoter activity). ChIP/ChIP-seq (protein-DNA binding). EMSA (gel shift, protein-DNA interaction). Bisulfite sequencing (DNA methylation). RNA-seq (transcriptome).
• Clinical correlates: HDAC inhibitors (vorinostat), DNMT inhibitors (azacitidine) — cancer therapy. Rett syndrome (MeCP2), Fragile X (FMR1 methylation), Prader-Willi/Angelman (imprinting defects at 15q11-q13).